398 related articles for article (PubMed ID: 11841370)
1. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement.
Venneker GT; Vodegel RM; Okada N; Westerhof W; Bos JD; Asghar SS
Immunobiology; 1998 Feb; 198(4):476-84. PubMed ID: 9562871
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes [corrected].
Pasch MC; Bos JD; Daha MR; Asghar SS
Eur J Immunol; 1999 Jan; 29(1):100-8. PubMed ID: 9933091
[TBL] [Abstract][Full Text] [Related]
5. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
6. Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endothelium.
Venneker GT; Das PK; Naafs B; Tigges AJ; Bos JD; Asghar SS
Br J Dermatol; 1994 Aug; 131(2):237-42. PubMed ID: 7522514
[TBL] [Abstract][Full Text] [Related]
7. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
8. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
[TBL] [Abstract][Full Text] [Related]
10. Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo.
van den Wijngaard RM; Aten J; Scheepmaker A; Le Poole IC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2000 Sep; 143(3):573-81. PubMed ID: 10971331
[TBL] [Abstract][Full Text] [Related]
11. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression.
Spiller OB; Moretto G; Kim SU; Morgan BP; Devine DV
J Neuroimmunol; 1996 Dec; 71(1-2):97-106. PubMed ID: 8982108
[TBL] [Abstract][Full Text] [Related]
12. Complement regulatory proteins on the sperm surface: relevance to sperm motility.
Jiang H; Pillai S
Am J Reprod Immunol; 1998 Apr; 39(4):243-8. PubMed ID: 9553648
[TBL] [Abstract][Full Text] [Related]
13. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha.
Cocuzzi ET; Bardenstein DS; Stavitsky A; Sundarraj N; Medof ME
Curr Eye Res; 2001 Aug; 23(2):86-92. PubMed ID: 11840345
[TBL] [Abstract][Full Text] [Related]
16. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues.
Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613
[TBL] [Abstract][Full Text] [Related]
17. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
[TBL] [Abstract][Full Text] [Related]
18. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
20. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
Miwa T; Song WC
Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
